169 related articles for article (PubMed ID: 31272132)
1. Role of Chlamydia trachomatis serology in conservative management of cervical intraepithelial neoplasia grade 2.
Miralpeix E; Solé-Sedeño JM; Agramunt S; Lloveras B; Gimeno R; Alameda F; Carreras R; Mancebo G
Int J Gynaecol Obstet; 2019 Oct; 147(1):43-48. PubMed ID: 31272132
[TBL] [Abstract][Full Text] [Related]
2. Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
Salvadó A; Miralpeix E; Solé-Sedeno JM; Kanjou N; Lloveras B; Duran X; Mancebo G
Gynecol Oncol; 2021 Sep; 162(3):569-574. PubMed ID: 34226019
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
Safaeian M; Quint K; Schiffman M; Rodriguez AC; Wacholder S; Herrero R; Hildesheim A; Viscidi RP; Quint W; Burk RD
J Natl Cancer Inst; 2010 Dec; 102(23):1794-804. PubMed ID: 21098758
[TBL] [Abstract][Full Text] [Related]
4. Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study.
Skorstengaard M; Lynge E; Suhr J; Napolitano G
BJOG; 2020 May; 127(6):729-736. PubMed ID: 31880054
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
7. Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil.
da Silva Barros NK; Costa MC; Alves RR; Villa LL; Derchain SF; Zeferino LC; Dos Santos Carneiro MA; Rabelo-Santos SH
J Med Virol; 2012 Jul; 84(7):1143-50. PubMed ID: 22585734
[TBL] [Abstract][Full Text] [Related]
8. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K;
J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758
[TBL] [Abstract][Full Text] [Related]
9. Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study.
Godfrey MAL; Nikolopoulos M; Garner JE; Adib TR; Mukhopadhyay D; Rains JS; Harper CA; Wuntakal R
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():267-273. PubMed ID: 30048921
[TBL] [Abstract][Full Text] [Related]
10. The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions.
Dovnik A; Poljak M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047452
[TBL] [Abstract][Full Text] [Related]
11. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
12. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
13. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
[TBL] [Abstract][Full Text] [Related]
14. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
[TBL] [Abstract][Full Text] [Related]
15. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience.
Hong DK; Kim SA; Lim KT; Lee KH; Kim TJ; So KA
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():173-176. PubMed ID: 30933887
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 Years.
Silver MI; Gage JC; Schiffman M; Fetterman B; Poitras NE; Lorey T; Cheung LC; Katki HA; Locke A; Kinney WK; Castle PE
Cancer Prev Res (Phila); 2018 Mar; 11(3):165-170. PubMed ID: 29437696
[TBL] [Abstract][Full Text] [Related]
18. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
19. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
20. Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort.
Castellsagué X; Pawlita M; Roura E; Margall N; Waterboer T; Bosch FX; de Sanjosé S; Gonzalez CA; Dillner J; Gram IT; Tjønneland A; Munk C; Pala V; Palli D; Khaw KT; Barnabas RV; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Fagherazzi G; Kaaks R; Lukanova A; Steffen A; Trichopoulou A; Trichopoulos D; Klinaki E; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Lund E; Weiderpass E; Quirós JR; Sánchez MJ; Navarro C; Barricarte A; Larrañaga N; Ekström J; Hortlund M; Lindquist D; Wareham N; Travis RC; Rinaldi S; Tommasino M; Franceschi S; Riboli E
Int J Cancer; 2014 Jul; 135(2):440-52. PubMed ID: 24338606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]